Curis Inc. is a NASDAQ listed security that has been trading in a range between $0.91 and $2.35 over the past year. With 49,381,520 shares outstanding, a recent price of $1.26 gives a total market capitalization of $63,702,159. While there are certainly larger companies, Curis Inc. has definitely earned its place in the pack. Last year, Curis Inc. created $-0.17 in earnings for every share outstanding.
Curis Inc. is currently priced by the market at 0.00 times last year’s earnings. Many trading multiples around the world are quite attractive these days, but don’t be fooled. A Price to Earnings ratio of 0 simply means that the security didn’t make any money last year.
With a share price under $50 a share and earnings per share below $1 a share, Curis Inc. is unlikely to be an interesting value proposition. Consistent earnings are the key to high valuations and this security is not on its way.
skip to main |
skip to sidebar
skip to left sidebar
"Even a Panic Is Not Altogether a Bad Thing" - F. A. Hayek
Donate via PayPal
Blog Archive
-
▼
2007
(1940)
-
▼
July
(1203)
- Amtrust Financial Services Inc.
- ANADIGICS Inc.
- Anadys Pharmaceuticals Inc.
- Analysts International Corporation
- Anaren Inc.
- Anesiva Inc.
- Answers Corporation
- Answerthink Inc.
- Antigenics Inc.
- APA Enterprises Inc.
- APAC Customer Services Inc.
- Appalachian Bancshares Inc
- Arbinet-thexchange Inc.
- Arden Group Inc.
- Arena Pharmaceuticals Inc.
- Ariad Pharmaceuticals Inc.
- Ariba Inc.
- Ark Restaurants Corp.
- Arotech Corporation
- ArQule Inc.
- Array BioPharma Inc.
- Arrowhead Research Corporation
- Art Technology Group Inc.
- Artes Medical Inc.
- Artesian Resources Corp.
- Aruba Networks Inc.
- Ashworth Inc.
- AsiaInfo Holdings Inc.
- Aspen Technology Inc.
- Astro-Med Inc.
- Astronics Corporation
- Asyst Technologies Inc.
- Atari Inc.
- AtheroGenics Inc.
- Atlantic American Corporation
- Atlantic Coast Federal Corporation
- Atlantic Southern Financial Group Inc.
- Atlantic Tele-Network Inc.
- AtriCure Inc.
- Atrion Corporation
- ATS Medical Inc.
- Attunity Ltd
- Audible Inc.
- AudioCodes Ltd.
- Audiovox Corporation
- Authentidate Holding Corp.
- Authorize.Net Holdings Inc.
- Autobytel Inc.
- Auxilium Pharmaceuticals Inc.
- Avalon Pharmaceuticals Inc.
- Avanex Corporation
- AVANIR Pharmaceuticals
- AVANT Immunotherapeutics Inc.
- AVI BioPharma Inc.
- Avici Systems Inc.
- Avigen Inc.
- Aviza Technology Inc.
- Aware Inc.
- Axcelis Technologies Inc.
- AXT Inc.
- B.O.S. Better OnLine Sol.
- Bakers Footwear Group Inc.
- Baldwin and Lyons Inc.
- BALLARD POWER SYSTEMS INC
- Bank of Commerce Holdings
- Bank of Florida Corporation
- BankFinancial Corporation
- Barrier Therapeutics Inc.
- Basin Water Inc.
- BCB Bancorp Inc.
- BCSB Bankcorp Inc.
- Beach First National Bancshares Inc
- Beasley Broadcast Group Inc.
- Beijing Med-Pharm Corporation
- Bell Microproducts Inc.
- Benihana Inc.
- Benjamin Franklin Bancorp Inc.
- Berkshire Bancorp Inc.
- Big Dog Holdings Inc.
- BigBand Networks Inc.
- Bioanalytical Systems Inc.
- BioCryst Pharmaceuticals Inc.
- Bioenvision Inc.
- Bio-Imaging Technologies Inc.
- Biolase Technology Inc.
- BioMarin Pharmaceutical Inc.
- BioMimetic Therapeutics Inc.
- BIOMIRA INC
- BioScrip Inc.
- BioSphere Medical Inc.
- Blue Coat Systems Inc.
- BluePhoenix Solutions Ltd.
- BNCCORP Inc.
- Boardwalk Bancorp Inc.
- BofI Holding Inc.
- Bonso Electronics International Inc.
- Bookham Inc.
- Borland Software Corp.
- Boston Communications Group Inc
- Bottomline Technologies
-
▼
July
(1203)
1 comments:
The attraction is that some of the Curis drugs inhibit the hedgehog pathway. Hedgehog inhibitors, like cyclopamine, have done amazing things in preclinical studies. They have in fact CURED the gold standard animal models of several human cancers. It is a red hot area of research. The world now awaits the results of human trials. The basic scientists have done all they can do. Now it is up to the clinicians.
Hence the speculation and gamble that they may have blockbuster drugs in their pipeline.
Post a Comment